Back to top

Image: Bigstock

Selecta Biosciences (SELB): Strong Industry, Solid Earnings Estimate Revisions

Read MoreHide Full Article

One stock that might be an intriguing choice for investors right now is Selecta Biosciences, Inc. (SELB - Free Report) . This is because this security in the Medical - Biomedical and Genetics space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Medical - Biomedical and Genetics space as it currently has a Zacks Industry Rank of 58 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Selecta Biosciences is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

SELECTA BIOSCI Price and Consensus

SELECTA BIOSCI Price and Consensus | SELECTA BIOSCI Quote

In fact, over the past month, current quarter estimates have risen from a loss of 51 cents per share to a gain of 32 cents per share, while current year estimates have narrowed from a loss of $1.72 per share to a loss of $1.15 per share. This has helped SELB to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider Selecta Biosciences. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.  

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?

Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Selecta Biosciences, Inc. (SELB) - free report >>